Plasma fibroblast growth factor 23, parathyroid hormone, 25-hydroxyvitamin D3, and risk of heart failure: a prospective, case-cohort study.
about
Role of vitamin D in diabetes mellitus and chronic kidney diseaseEndocrine FGFs: Evolution, Physiology, Pathophysiology, and PharmacotherapyPlasma osteoprotegerin, its correlates, and risk of heart failure: a prospective cohort study.Potential Predictors of Plasma Fibroblast Growth Factor 23 Concentrations: Cross-Sectional Analysis in the EPIC-Germany StudyFibroblast growth factor-23 in obese, normotensive adolescents is associated with adverse cardiac structure.Relationship between N-terminal pro-brain natriuretic peptide, obesity and the risk of heart failure in middle-aged German adults.Serum parathyroid hormone and 25-hydroxyvitamin D concentrations and risk of incident heart failure: the Multi-Ethnic Study of Atherosclerosis.1,25-Dihydroxyvitamin D to PTH(1-84) Ratios Strongly Predict Cardiovascular Death in Heart Failure.Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgeryParathyroid hormone and risk of heart failure in the general population: A meta-analysis of prospective studiesVitamin D and Heart Failure.Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical Illness.Fibroblast growth factor 23 and heart failure: the plot thickens.Association between circulating FGF23, α-Klotho, and left ventricular diastolic dysfunction among patients with preserved ejection fraction.Association of Fibroblast Growth Factor 23 With Risk of Incident Coronary Heart Disease in Community-Living Adults.Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease.Phosphate and Cardiovascular Disease beyond Chronic Kidney Disease and Vascular Calcification.The Role of Parathyroid Hormone and Vitamin D Serum Concentrations in Patients with Cardiovascular Diseases.
P2860
Q26765231-270E4473-C2D0-4ACF-91C7-0FB755F68DC8Q26781556-8F0CE42B-02E5-4232-B214-B7DA66652E20Q30314414-BA4B9394-9930-4687-BBF1-2DC95EB27BC3Q30316351-F0A5E8D3-6618-48A2-ADF2-CC5ECE3DBF32Q34255342-C6ECE1CB-F899-4C9F-BAF2-F07978681954Q34571982-838C1634-41F6-49D5-B5EE-2348194F0CE4Q35115028-5A38C2AC-BCD8-4739-806E-4786113375ADQ35755817-54B03F14-65E3-458C-ADF3-A17B200C9627Q36711992-14E0097F-237D-413E-B0B4-315156FA0017Q37328775-10092148-34B1-41DC-AE9F-00608EC8ED61Q38624627-F7628182-D074-4305-80E9-876E90FFDA89Q40405562-9E5B36BD-5CE1-421C-A6B1-2C019880B5EAQ41091515-AB2193BA-0C00-4395-AC69-C1C3AD55A3DAQ48541526-E0C05D74-EB8B-4149-A34D-4EF202AC161AQ52667905-97FF8468-CF27-42CF-AC22-918F7DC275E0Q53172065-838BABF9-BFE6-4574-B33C-FC9BA6A1D0DCQ55098165-8D101EA3-4B9E-42F8-B334-B8D1E994C392Q55447721-7F14205F-3E4C-4251-B9A5-8E2353EE3772
P2860
Plasma fibroblast growth factor 23, parathyroid hormone, 25-hydroxyvitamin D3, and risk of heart failure: a prospective, case-cohort study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Plasma fibroblast growth facto ...... rospective, case-cohort study.
@en
Plasma fibroblast growth facto ...... rospective, case-cohort study.
@nl
type
label
Plasma fibroblast growth facto ...... rospective, case-cohort study.
@en
Plasma fibroblast growth facto ...... rospective, case-cohort study.
@nl
prefLabel
Plasma fibroblast growth facto ...... rospective, case-cohort study.
@en
Plasma fibroblast growth facto ...... rospective, case-cohort study.
@nl
P2093
P50
P356
P1476
Plasma fibroblast growth facto ...... rospective, case-cohort study.
@en
P2093
Berend Isermann
Brian Buijsse
Cornelia Weikert
Frank Hirche
Gabriele I Stangl
Hans W Hense
Janine Wirth
Jutta Dierkes
Sabine Westphal
P304
P356
10.1210/JC.2013-2963
P407
P577
2013-01-01T00:00:00Z